Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
P. Ruiz, E. Myshkin, P. Quigley, O. Faroon, J.S. Wheeler, M.M. Mumtaz & R.J. Brennan. (2013) Assessment of hydroxylated metabolites of polychlorinated biphenyls as potential xenoestrogens: a QSAR comparative analysis∗
. SAR and QSAR in Environmental Research 24:5, pages 393-416.
Read now
Read now
E. Fioravanzo, A. Bassan, M. Pavan, A. Mostrag-Szlichtyng & A.P. Worth. (2012) Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities. SAR and QSAR in Environmental Research 23:3-4, pages 257-277.
Read now
Read now
Robert D Combes. (2011) Challenges for computational structure–activity modelling for predicting chemical toxicity: future improvements?. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1129-1140.
Read now
Read now
Edwin J. Matthews, Naomi L. Kruhlak, R. Daniel Benz, Joseph F. Contrera, Carol A. Marchant & Chihae Yang. (2008) Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in Rodents. Toxicology Mechanisms and Methods 18:2-3, pages 189-206.
Read now
Read now
Romualdo Benigni & Cecilia Bossa. (2008) Predictivity and Reliability of QSAR Models: The Case of Mutagens and Carcinogens. Toxicology Mechanisms and Methods 18:2-3, pages 137-147.
Read now
Read now
Articles from other publishers (25)
Nermin A. Osman. (2022)
Statistical methods for
in silico
tools used for risk assessment and toxicology
. Physical Sciences Reviews 0:0.
Crossref
Crossref
Rafael Gozalbes & Jesús Vicente de Julián-Ortiz. (2018) Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation. International Journal of Quantitative Structure-Property Relationships 3:1, pages 1-24.
Crossref
Crossref
K.S. Ramos & P. Bojang Jr. 2018. Comprehensive Toxicology. Comprehensive Toxicology
463
474
.
K.S. Ramos, T. Camenisch & Q. He. 2018. Comprehensive Toxicology. Comprehensive Toxicology
664
679
.
Patricia Ruiz, Kundan Ingale, John S. Wheeler & Moiz Mumtaz. (2016) 3D QSAR studies of hydroxylated polychlorinated biphenyls as potential xenoestrogens. Chemosphere 144, pages 2238-2246.
Crossref
Crossref
Benoît Schilter, Romualdo Benigni, Alan Boobis, Alessandro Chiodini, Andrew Cockburn, Mark T.D. Cronin, Elena Lo Piparo, Sandeep Modi, Anette Thiel & Andrew Worth. (2014) Establishing the level of safety concern for chemicals in food without the need for toxicity testing. Regulatory Toxicology and Pharmacology 68:2, pages 275-296.
Crossref
Crossref
Luis G. ValerioJrJr & Supratim Choudhuri. (2012)
Chemoinformatics and chemical genomics: potential utility of
in silico
methods
. Journal of Applied Toxicology 32:11, pages 880-889.
Crossref
Crossref
Alexander V. LyubimovRichard J. Dimelow, Paul D. Metcalfe & Simon Thomas. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
55
.
Yvonne Connolly Martin. (2012) Hansch analysis 50 years on. WIREs Computational Molecular Science 2:3, pages 435-442.
Crossref
Crossref
N L Kruhlak, R D Benz, H Zhou & T J Colatsky. (2012) (Q)SAR Modeling and Safety Assessment in Regulatory Review. Clinical Pharmacology & Therapeutics 91:3, pages 529-534.
Crossref
Crossref
Robert D. Combes. 2012. New Technologies for Toxicity Testing. New Technologies for Toxicity Testing
96
116
.
. 2010. Risk Assessment of Phytochemicals in Food. Risk Assessment of Phytochemicals in Food
38
159
.
Ovanes MekenyanJ. C. Dearden. 2010. In Silico Toxicology. In Silico Toxicology
478
507
.
Joel P. Bercu, Stuart M. Morton, J. Thom Deahl, Vijay K. Gombar, Courtney M. Callis & Robert B.L. van Lier. (2010) In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances. Regulatory Toxicology and Pharmacology 57:2-3, pages 300-306.
Crossref
Crossref
Edwin J. Matthews & Anna A. Frid. (2010) Prediction of drug-related cardiac adverse effects in humans—A: Creation of a database of effects and identification of factors affecting their occurrence. Regulatory Toxicology and Pharmacology 56:3, pages 247-275.
Crossref
Crossref
Anna A. Frid & Edwin J. Matthews. (2010) Prediction of drug-related cardiac adverse effects in humans-B: Use of QSAR programs for early detection of drug-induced cardiac toxicities. Regulatory Toxicology and Pharmacology 56:3, pages 276-289.
Crossref
Crossref
Tomasz Grabowski, Jerzy Jan Jaroszewski & Walerian Piotrowski. (2010) Correlations between no observed effect level and selected parameters of the chemical structure for veterinary drugs. Toxicology in Vitro 24:3, pages 953-959.
Crossref
Crossref
Luis G. ValerioJr.Jr., Kirk B. Arvidson, Emily Busta, Barbara L. Minnier, Naomi L. Kruhlak & R. Daniel Benz. (2010) Testing computational toxicology models with phytochemicals. Molecular Nutrition & Food Research 54:2, pages 186-194.
Crossref
Crossref
K.S. Ramos, Q. He & H. Gao. 2010. Comprehensive Toxicology. Comprehensive Toxicology
623
640
.
David W. Hobson. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Ronald D. Snyder. (2009) An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity. Environmental and Molecular Mutagenesis 50:6, pages 435-450.
Crossref
Crossref
Edwin J. Matthews, Carling J. Ursem, Naomi L. Kruhlak, R. Daniel Benz, David Aragonés Sabaté, Chihae Yang, Gilles Klopman & Joseph F. Contrera. (2009) Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities. Regulatory Toxicology and Pharmacology 54:1, pages 23-42.
Crossref
Crossref
Edwin J. Matthews, Naomi L. Kruhlak, R. Daniel Benz, David Aragonés Sabaté, Carol A. Marchant & Joseph F. Contrera. (2009) Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities. Regulatory Toxicology and Pharmacology 54:1, pages 43-65.
Crossref
Crossref
Krista L. Dobo, R. Scott Obach, Debra Luffer-Atlas & Joel P. Bercu. (2009) A Strategy for the Risk Assessment of Human Genotoxic Metabolites. Chemical Research in Toxicology 22:2, pages 348-356.
Crossref
Crossref
LG Valerio. (2008) Tools for evidence-based toxicology: computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Human & Experimental Toxicology 27:10, pages 757-760.
Crossref
Crossref